Salim S Hayek1, Yi-An Ko2, Mosaab Awad1, Andrea Del Mar Soto1, Hina Ahmed1, Keyur Patel1, Michael Yuan3, Spencer Maddox4, Brandon Gray1, Jamal Hajjari4, Laurence Sperling1, Amit Shah5, Viola Vaccarino5, Arshed A Quyyumi6. 1. Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States. 2. Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, United States. 3. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States. 4. Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States. 5. Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States. 6. Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States. Electronic address: aquyyum@emory.edu.
Abstract
BACKGROUND: Depression is common in patients with coronary artery disease (CAD) and is associated with more frequent chest pain. It is however unclear whether this is due to differences in underlying CAD severity. We sought to determine [1] whether depressive symptoms are associated with chest pain independently of CAD severity, [2] whether improvement in depressive symptoms over time is associated with improvement in chest pain and [3] whether the impact of revascularization on chest pain differs between patients with and without depression. METHODS AND RESULTS: 5158 patients (mean age 63±12years, 65% male, 20% African American) undergoing cardiac catheterization completed the Seattle Angina Questionnaire (SAQ) and Patient Health Questionnaire-8 (PHQ-8) to assess angina severity and screen for depression, respectively, both at baseline and between 6 and 24months of follow-up. We found significant correlations between PHQ-8 scores and angina frequency (SAQ-AF, r=-0.28), physical limitation (SAQ-PL, r=-0.32) and disease perception (SAQ-DS r=-0.37, all P<0.001), which remained significant after adjustment for clinical characteristics, CAD severity, and anti-depressant use. Improvement in depressive symptoms at follow-up was associated with improvement in angina subscales (SAQ-AF β 1.34, P<0.001), SAQ-PL β 1.85, P<0.001), and SAQ-DS (β 2.12, P<0.001), independently of CAD severity or revascularization. Patients with depression who underwent revascularization had less improvement in chest pain frequency than those without depressive symptoms. CONCLUSIONS: Depression is associated with angina, independently of CAD severity. Patients with depression may not derive as adequate symptomatic benefit from revascularization as those without. Whether treatment of underlying depression improves chest pain needs to be further studied.
BACKGROUND:Depression is common in patients with coronary artery disease (CAD) and is associated with more frequent chest pain. It is however unclear whether this is due to differences in underlying CAD severity. We sought to determine [1] whether depressive symptoms are associated with chest pain independently of CAD severity, [2] whether improvement in depressive symptoms over time is associated with improvement in chest pain and [3] whether the impact of revascularization on chest pain differs between patients with and without depression. METHODS AND RESULTS: 5158 patients (mean age 63±12years, 65% male, 20% African American) undergoing cardiac catheterization completed the Seattle Angina Questionnaire (SAQ) and Patient Health Questionnaire-8 (PHQ-8) to assess angina severity and screen for depression, respectively, both at baseline and between 6 and 24months of follow-up. We found significant correlations between PHQ-8 scores and angina frequency (SAQ-AF, r=-0.28), physical limitation (SAQ-PL, r=-0.32) and disease perception (SAQ-DS r=-0.37, all P<0.001), which remained significant after adjustment for clinical characteristics, CAD severity, and anti-depressant use. Improvement in depressive symptoms at follow-up was associated with improvement in angina subscales (SAQ-AF β 1.34, P<0.001), SAQ-PL β 1.85, P<0.001), and SAQ-DS (β 2.12, P<0.001), independently of CAD severity or revascularization. Patients with depression who underwent revascularization had less improvement in chest pain frequency than those without depressive symptoms. CONCLUSIONS:Depression is associated with angina, independently of CAD severity. Patients with depression may not derive as adequate symptomatic benefit from revascularization as those without. Whether treatment of underlying depression improves chest pain needs to be further studied.
Authors: Ranak Trivedi; Martha Gerrity; John S Rumsfeld; John A Spertus; Haili Sun; Mary McDonell; Melanie Doak; Linda Lucas; Stephan D Fihn Journal: Ann Behav Med Date: 2015-02
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Jeff C Huffman; Christopher M Celano; Scott R Beach; Shweta R Motiwala; James L Januzzi Journal: Cardiovasc Psychiatry Neurol Date: 2013-04-07
Authors: Amit J Shah; Nima Ghasemzadeh; Elisa Zaragoza-Macias; Riyaz Patel; Danny J Eapen; Ian J Neeland; Pratik M Pimple; A Maziar Zafari; Arshed A Quyyumi; Viola Vaccarino Journal: J Am Heart Assoc Date: 2014-06-18 Impact factor: 5.501
Authors: Shazia Jehan; Evan Auguste; Seithikurippu R Pandi-Perumal; Jolaade Kalinowski; Alyson K Myers; Ferdinand Zizi; Madhu G Rajanna; Girardin Jean-Louis; Samy I McFarlane Journal: Sleep Med Disord Date: 2017-10-27
Authors: Pratik Pimple; Muhammad Hammadah; Kobina Wilmot; Ronnie Ramadan; Ibhar Al Mheid; Oleksiy Levantsevych; Samaah Sullivan; Ernest V Garcia; Jonathon Nye; Amit J Shah; Laura Ward; Puja Mehta; Paolo Raggi; J Douglas Bremner; Arshed A Quyyumi; Viola Vaccarino Journal: Am J Med Date: 2017-12-07 Impact factor: 4.965
Authors: Matthew T Wittbrodt; Kasra Moazzami; Amit J Shah; Bruno B Lima; Muhammad Hammadah; Puja K Mehta; Arshed A Quyyumi; Viola Vaccarino; Jonathon A Nye; J Douglas Bremner Journal: J Psychosom Res Date: 2020-04-11 Impact factor: 3.006
Authors: Kasra Moazzami; Matthew T Wittbrodt; Mhmtjamil Alkhalaf; Bruno B Lima; Jonathon A Nye; Puja K Mehta; Arshed A Quyyumi; Viola Vaccarino; J Douglas Bremner; Amit J Shah Journal: Circ Cardiovasc Imaging Date: 2020-08-10 Impact factor: 7.792
Authors: Miodrag Jovan Sreckovic; Nikola Jagic; Vladimir Miloradovic; Aleksandar Neskovic; Ivan Soldatovic; Ilija Srdanovic Journal: Postepy Kardiol Interwencyjnej Date: 2017-05-25 Impact factor: 1.426
Authors: Anna Meta Dyrvig Kristensen; Ann Bovin; Ann Dorthe Zwisler; Charlotte Cerquira; Christian Torp-Pedersen; Hans Erik Bøtker; Ida Gustafsson; Karsten Tange Veien; Kristian Korsgaard Thomsen; Michael Hecht Olsen; Mogens Lytken Larsen; Olav Wendelboe Nielsen; Per Hildebrandt; Sussie Foghmar; Svend Eggert Jensen; Theis Lange; Thomas Sehested; Tomas Jernberg; Dan Atar; Borja Ibanez; Eva Prescott Journal: Trials Date: 2020-05-23 Impact factor: 2.279